Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs Cronos Group Inc (CRON) Price & Performance

Adaptive Biotechnologies CorpTrade
Cronos Group IncTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs Cronos Group Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Cronos Group Inc trades at $3.08 (market cap $1.14B). The key difference: Adaptive Biotechnologies Corp is far larger — about 3.5× Cronos Group Inc's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, Cronos Group Inc nearer its low. Which is the better fit depends on your goals.

ADPTCRON
Market Cap
$4.04B$1.14B
Sector
HealthHealth
52-Week High
$25.45$3.27
52-Week Low
$12.30$2.30
Enterprise Value
$4.10B$341.13M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON